Hillsdale Investment Management Inc. Has $714,000 Stake in Cigna Group $CI

Hillsdale Investment Management Inc. trimmed its position in shares of Cigna Group (NYSE:CI) by 10.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,160 shares of the health services provider’s stock after selling 250 shares during the period. Hillsdale Investment Management Inc.’s holdings in Cigna Group were worth $714,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CI. Valeo Financial Advisors LLC lifted its position in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares during the last quarter. Nuveen LLC bought a new position in Cigna Group in the 1st quarter worth approximately $727,905,000. Price T Rowe Associates Inc. MD increased its position in Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock worth $3,966,690,000 after buying an additional 1,094,327 shares during the period. GQG Partners LLC lifted its holdings in shares of Cigna Group by 21.5% during the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock worth $1,607,716,000 after buying an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Cigna Group by 38.3% in the first quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after acquiring an additional 457,052 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CI shares. Sanford C. Bernstein dropped their target price on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research report on Wednesday, November 12th. Wolfe Research dropped their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Cowen reissued a “buy” rating on shares of Cigna Group in a research report on Tuesday, November 4th. Finally, Cantor Fitzgerald lowered their price target on Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $334.05.

Cigna Group Price Performance

NYSE:CI opened at $278.12 on Monday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a 50-day moving average of $286.74 and a 200-day moving average of $298.69. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a market capitalization of $74.29 billion, a price-to-earnings ratio of 15.18, a PEG ratio of 0.88 and a beta of 0.44.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.64%.

Insider Activity at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is owned by company insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.